Key facts
- It has raised $54.0M across 7 recorded rounds; the latest was Early Stage VC ($8.1M) in May 2025.
- Notable investors include Bon Secours Mercy Health, F9 Investments, Taglich Brothers.
- Dilon Technologies has filed 24 Form Ds with the SEC since 2008, most recently Jul 2025 ($1.9M sold to 46 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 7 rounds
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Dilon Technologies
Funding rounds
7 roundsAbout Dilon Technologies
Manufacturer of medical imaging devices designed to focus on products that assist in the fight against breast cancer. The company's devices focus on improving the quality of life by providing a wide range of innovative medical tools that benefit patients, enabling clients to precisely identify tumor lesions in resected or biopsied breast tissue.
- Sector
- Healthcare
- HQ
- Newport News, VA, United States
- Founded
- 1997
- Employees
- 93
- Website
- dilon.com/
- Ownership
- Privately Held (backing)
Dilon Technologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Dilon Technologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Dilon Technologies in its N-PORT filings yet. We sweep new filings monthly.